English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Lundbeck
Carol Ostrow
| Jan 12, 2018
Lundbeck teams up with Vanderbilt on schizophrenia treatment
Robert Hadley
| Mar 30, 2017
Europe to evaluate antipsychotic drug for approval
Amanda Rupp
| Aug 8, 2016
FDA gives idalopirdine Fast Track Designation
Jamie Barrand
| Feb 10, 2016
Manufacturers hope to expand labeling on schizophrenia therapy
Wendell Hutson
| Sep 20, 2015
Brintellix gets drug approval by FDA
Trending
Patient Daily
| Aug 18, 2025
Medfluence Advisors’ Greg Caesar to open ASCENT 2025 with keynote on digital practice growth
+
Pharmaceuticals
Patient Daily
| Aug 18, 2025
Patients Come First spokesperson on 340B rebate model: ‘This rebate model provides the oversight that 340B has needed for decades’
Patient Daily
| Aug 21, 2025
SoCal Breathe Free doctor on balloon sinuplasty: ‘The procedure itself is pretty quick and effectiveness is pretty high’
+
Pharmaceuticals
Patient Daily
| Aug 21, 2025
PhRMA director of public affairs on 340B rebate model: "Positive first step toward addressing hospital abuse of the 340B program
